These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 11815396)
1. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396 [TBL] [Abstract][Full Text] [Related]
2. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855 [TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111 [TBL] [Abstract][Full Text] [Related]
5. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770 [TBL] [Abstract][Full Text] [Related]
6. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242 [TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898 [TBL] [Abstract][Full Text] [Related]
9. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908 [TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G; Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464 [TBL] [Abstract][Full Text] [Related]
11. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321 [TBL] [Abstract][Full Text] [Related]
12. Association between lung cancer and microsomal epoxide hydrolase genotypes. Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050 [TBL] [Abstract][Full Text] [Related]
13. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221 [TBL] [Abstract][Full Text] [Related]
14. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Schneider J; Bernges U; Philipp M; Woitowitz HJ Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047 [TBL] [Abstract][Full Text] [Related]
15. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594 [TBL] [Abstract][Full Text] [Related]
16. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility. Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403 [TBL] [Abstract][Full Text] [Related]
17. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Zhou W; Liu G; Park S; Wang Z; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):491-6. PubMed ID: 15734977 [TBL] [Abstract][Full Text] [Related]
18. Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer. Lacko M; Roelofs HM; Te Morsche RH; Voogd AC; Oude Ophuis MB; Peters WH; Manni JJ Head Neck; 2008 Jul; 30(7):836-44. PubMed ID: 18383527 [TBL] [Abstract][Full Text] [Related]
19. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012 [TBL] [Abstract][Full Text] [Related]
20. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Ulrich CM; Bigler J; Whitton JA; Bostick R; Fosdick L; Potter JD Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):875-82. PubMed ID: 11489754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]